Navigation Links
FASEB announces 2014 SRC: Phospholipid Cell Signaling & Metabolism in Inflammation & Cancer
Date:1/22/2014

Bethesda, MD The main topics are: signal transduction, cancer, inflammation, lipid imaging and therapeutics. The goals of the meeting are to include cutting-edge topics in phospholipid metabolism and cell signaling that include a strong component in translation to human diseases. Out of the 4 recognized diseases that lipids are known to play a role (type-II diabetes, heart and vascular diseases, inflammation and cancer) we have chosen to concentrate on inflammation and cancer as the other two are amply covered in other scientific meetings. As such, we are broadening considerably the target audience with investigators in those areas, keeping the right balance with the existing interest of more regular attendees.

These objectives will be pursued through the following topics to be covered at the meeting.

  • New cellular and molecular signal transduction research by phospholipases A2, C and D, diacylglycerol kinase, phosphatidate phosphatases, and phosphatidylinositol kinases and impact on inflammation, cell proliferation and tumorigenesis.
  • Genetic, transcriptional and biochemical regulation of lipid metabolism and pathways interconnectivity.
  • New approaches to visualization of membrane and organelle trafficking: endocytosis, organelle biogenesis, phagocytosis, mitochondrial and nuclear function.
  • The molecular basis of inflammation and cancer based on anomalous lipid signaling.
  • Biotechnology translation with recent advances in delivery systems of lipids (e.g., nanoparticles) as therapeutics in cancer treatment.

Recruitment of Speakers

As a truly international conference, in addition to USA researchers, we will have speakers from Canada, UK, Japan, Spain, Italy and South Korea and more countries are expected to be represented from Abstracts. We have enlisted several Howard Hughes Medical Investigator Researchers, members of the National Academy of Sciences (USA) and top-ranking Journal Editors. A great effort will be made to reserve many slots for young investigators at the conference and 3-meet the experts sessions have been booked.


'/>"/>

Contact: Robin Crawford
src@faseb.org
301-634-7010
Federation of American Societies for Experimental Biology
Source:Eurekalert

Related biology news :

1. FASEB announces 2014 Science Research Conference: Molecular Biophysics of Membranes
2. FASEB announces 2014 SRC: Translational Neuroimmunology: From Mechanisms to Therapeutics
3. FASEB announces 2014 Science Research Conference: Nutrient Sensing and Metabolic Signaling
4. FASEB announces 2014 Science Research Conference: Retinal Neurobiology and Visual Processing
5. FASEB announces 2014 Science Research Conference: Virus Structure and Assembly
6. FASEB announces 2014 Science Research Conference: Protein Folding in the Cell
7. FASEB announces 2014 Science Research Conference: 2nd International Conference on Retinoids
8. FASEB announces SRC: Molecular Mechanisms of Intestinal Lipid Transport & Metabolism
9. FASEB announces 2014 SRC: Protein Phosphorylation, Cellular Plasticity & Signaling Rewiring
10. FASEB announces 2014 SRC: Protein Interactions, Structures, Technologies & Networks
11. FASEB announces 2014 Science Research Conference: Biology & Pathobiology of Krueppel-Like Factors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/20/2016)... 20, 2016 The rising popularity of ... leasing is stoking significant interest in keyless access ... Bluetooth low energy (BLE), biometrics and near-field communication ... wave of wireless technologies in the automotive industry. ... advanced access systems opens the market to specialist ...
(Date:12/19/2016)... TORONTO , 19 de diciembre de 2016  Mosaic Biomedicals ... el desarrollo acelerado de MSC-1, un anticuerpo humanizado que se espera ... en 2017, con múltiples sitios previstos a lo largo de Europa ... MSC-1 ... factor inhibidor de leucemia (LIF), una citoquina pleiotrópica que se sobreexpresa ...
(Date:12/16/2016)... DUBLIN , Dec 16, 2016 Research ... Access System Market - Global Forecast to 2021" report to ... ... projected to grow at a CAGR of 14.06% from 2016 to ... 2016, and is projected to reach 854.8 Million by 2021. The ...
Breaking Biology News(10 mins):
(Date:1/19/2017)... 19, 2017 Research and Markets ... has announced the addition of the ... Forecast to 2025" report to their offering. ... The report provides a detailed analysis on current and future market trends ... using estimated market values as the base numbers Key ...
(Date:1/19/2017)... GAITHERSBURG, Md. , Jan. 19, 2017 /PRNewswire/ ... a privately-held immunotherapeutics company targeting infectious diseases, announced ... the merger of PharmAthene and Altimmune in an ... Fund, HealthCap, Truffle Capital and Redmont Capital. The ... immunotherapeutics company with four clinical stage and one ...
(Date:1/19/2017)... , ... January 18, 2017 , ... ... Institutes of Health (NIH) to update its Data Sharing Policy. Specifically, the nation’s ... of grant applications subject to the existing policy. AMIA recommended that NIH earmark ...
(Date:1/19/2017)... ... 2017 , ... DaVita Clinical Research (DCR), a ... device development, and Prism Clinical Research , a leader in providing fully ... Clinical Trials (VCT) has been selected by both companies as an exclusive ...
Breaking Biology Technology: